Joe Copia's daytrades/investments and thoughts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Wayne Rumball who wrote (2466)	5/13/1998 11:23:00 AM
From: Joe Copia	Read Replies (2) of 25711

VXCL news. To: Joe Copia (0 ) From: Peter C. Overhoff Wednesday, May 13 1998 10:58AM ET Reply # of 15 Interesting news on VXCL! Read the comments! Wednesday May 13, 9:57 am Eastern Time Company Press Release SOURCE: Vaxcel, Inc. Vaxcel Announces Second Quarter Results ATLANTA, May 13 /PRNewswire/ -- Vaxcel, Inc. (OTC Bulletin Board: VXCL - news) today announced a net loss of $506,048 ($0.05 per share) for the first quarter of 1998 compared to a net loss of $342,973 ($0.04 per share) for the same period last year. ''In March we acquired the exclusive rights to the Beta-Human Chorionic Gonadotropin (BhCG) proteins for the use in the treatment and/or prevention of cancer,'' reported Paul J. Wilson, President and CEO of Vaxcel. ''We are still pursuing licensing and other opportunities for our injectable, oral, and mucosal technologies.'' Additionally, the Vaxcel board of directors has retained the investment banking firm of Interstate/Johnson Lane Corporation to introduce Vaxcel and its technologies to the trade with the purpose of concluding a strategic transaction for the benefit of the Vaxcel shareholders. [emphasis added] biz.yahoo.com Joe PTG&LI !!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next